| Autor: |
Matthew J. Price, David Slotwiner, Chengan Du, James V. Freeman, Zoltan Turi, Chidambaram Rammohan, Fred M. Kusumoto, Clifford Kavinsky, Joseph Akar, Paul D. Varosy, Christina Koutras, Jeptha P. Curtis, Frederick A. Masoudi |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
JACC. Cardiovascular interventions. 15(7) |
| ISSN: |
1876-7605 |
| Popis: |
The aim of this study was to report 1-year clinical outcomes following commercial transcatheter left atrial appendage occlusion (LAAO) in the United States.The National Cardiovascular Data Registry LAAO Registry was initiated to meet a condition of Medicare coverage and allow the assessment of clinical outcomes. The 1-year rates of thromboembolic events after transcatheter LAAO in such a large cohort of "real-world" patients have not been previously reported.Patients entered into the National Cardiovascular Data Registry LAAO Registry for a Watchman procedure between January 1, 2016, and December 31, 2018, were included. The primary endpoint was ischemic stroke. Key secondary endpoints included the rate of ischemic stroke or systemic embolism, mortality, and major bleeding. Major bleeding was defined as any bleeding requiring hospitalization, and/or causing a decrease in hemoglobin level2g/dL, and/or requiring blood transfusion that was not hemorrhagic stroke. The Kaplan-Meier method was used for 1-year estimates of cumulative event rates.The study population consisted of 36,681 patients. The mean age was 76.0 ± 8.1 years, the mean CHAThis study characterizes important outcomes in a national cohort of patients undergoing transcatheter LAAO in the United States. Clinicians and patients can integrate these data in shared decision making when considering this therapy. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
